Bristol-Myers Squibb Co (BUE:BMY) Short-Term Capital Lease Obligation : ARS142,383 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Short-Term Capital Lease Obligation?

Bristol-Myers Squibb Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ARS142,383 Mil.

Bristol-Myers Squibb Co's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (ARS52,493 Mil) to Dec. 2023 (ARS58,482 Mil) and increased from Dec. 2023 (ARS58,482 Mil) to Mar. 2024 (ARS142,383 Mil).

Bristol-Myers Squibb Co's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (ARS17,067 Mil) to Dec. 2022 (ARS22,800 Mil) and increased from Dec. 2022 (ARS22,800 Mil) to Dec. 2023 (ARS58,482 Mil).

Bristol-Myers Squibb Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Bristol-Myers Squibb Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Short-Term Capital Lease Obligation Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

7,949.89

13,346.32

17,067.31

22,800.40

58,482.00

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															33,781.05	40,320.00	52,492.50	58,482.00	142,382.50

Bristol-Myers Squibb Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Bristol-Myers Squibb Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (BUE:BMY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BUE:BMY) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.